Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2006
05/10/2006CN1255424C Method for preparing injection ribonucleic acid of human placenta
05/10/2006CN1255422C Nucleosides
05/10/2006CN1255421C Process for preparation of L-ribavirin
05/10/2006CN1255420C Process for preparation of L-ribavirin
05/10/2006CN1255413C (Pyrido/thieno)-[f]-oxazepin-5-one derivatives as AMPA receptor positive regulator
05/10/2006CN1255411C Benzoxathiepino [3,4-b] pyridine derivatives, process for their preparation and their use as medicaments
05/10/2006CN1255407C Substituted 3,4-dihydro-pyrido [1,2-a] pyrimidines
05/10/2006CN1255406C Substituted 2-acyl-3-(heteroaryl)-imidazo [1,2-a] pyrimidines, and related pharmaceutical compoistions and methods
05/10/2006CN1255405C Substituted pyrazoles
05/10/2006CN1255403C Beta-carboline derivatives useful as inhibitors of phosphodiesterase
05/10/2006CN1255401C Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists
05/10/2006CN1255397C Lactone category compound of sweetsop as well as new usage in medicines and its preparing method
05/10/2006CN1255396C Carboxylic acid derivatives having fused rings
05/10/2006CN1255392C Colchinol derivatives as angiogenesis inhibitors
05/10/2006CN1255391C COLCHINOL derivatives as vascular damaging agents
05/10/2006CN1255389C Morpholol with medicinal activity
05/10/2006CN1255387C Pyrimidine derivatives useful as selective COX-2 inhibitors
05/10/2006CN1255386C Substituted fused heterocyclic compounds
05/10/2006CN1255382C Modulators of dopamine neurotransmission
05/10/2006CN1255381C Indigo derivative and its preparing process and application
05/10/2006CN1255185C Pharmaceutical dosage form of amorphous nelfinavir mesylate
05/10/2006CN1255175C Chinese traditional medicine for treating cirrhosis ascites
05/10/2006CN1255172C Medical paste for rheumatism and bone ache
05/10/2006CN1255167C Anti-oxidation health care nutrient oil
05/10/2006CN1255161C Medication for relieving cough and asthma
05/10/2006CN1255151C Compound Longxue scorpion and preparation method thereof
05/10/2006CN1255144C Health care medicinal composition for regulating blood fat and its preparation
05/10/2006CN1255141C Chinese traditional medicine for treating tuberculosis
05/10/2006CN1255134C Externally applied medicinal ointment for treating burns, scalds and piles
05/10/2006CN1255128C Toothache-treating medicine
05/10/2006CN1255127C Medicine for treating toothache and preparation process thereof
05/10/2006CN1255122C Freeze dried powder injection of rhodiola root and its preparation process
05/10/2006CN1255121C Method for preparing Gadol pharmaceutical preparation
05/10/2006CN1255115C Pharmaceutical product containing rare earth for treating acne and preparing method thereof
05/10/2006CN1255114C Amphotericin B aqueous composition
05/10/2006CN1255113C Cell growth regulating factor D and its preparation process
05/10/2006CN1255112C Cell growth regulating factor E and its preparation process
05/10/2006CN1255111C Azithromycin soft capsule and its preparation method
05/10/2006CN1255110C Chinese medicinal composition for treating coronary heart disease and its usage
05/10/2006CN1255109C Method for producing entomogenous fungi preparation
05/10/2006CN1255108C Preparation process of Xuesaitong guttate pills
05/10/2006CN1255107C Composition of mifepristone semi-solid skeleton preparation
05/10/2006CN1255106C Complex artemisia apiacea extract
05/10/2006CN1255105C Water soluble dressing materials of ziracitone and its salts and their preparation
05/10/2006CN1255104C Camptothecine and hydroxy camptothecine lipid composition and its preparing method
05/10/2006CN1255103C Diaryl cycloalkyl derivatives, the use thereof as PPAR activators and pharmaceutical compositions containing thereof
05/10/2006CN1255102C Dripping pills of compound allantoin
05/10/2006CN1255101C Antibacterial disinfectant for cracking DNA of bacteria
05/10/2006CN1255100C Soft capsule preparation of Tibet medicine 'unique taste' and preparation method thereof
05/10/2006CN1255099C Method for encapsulating active substance
05/10/2006CN1255098C Ophiopogonin enteric coated microsphere preparation and preparing process thereof
05/10/2006CN1255097C Compound zedoary oil ointment and its preparing method
05/10/2006CN1255090C Skin care product containing A retinoid, A retinoid booster and phytoestrogens in a dual compartment package
05/09/2006USRE39094 absorb light further in the red, optimizing tissue penetration and are retained in the skin for short time periods relative to other drugs used in photodynamic cancer therapy
05/09/2006US7041863 Zeolite Y alkylation catalysts
05/09/2006US7041851 Diagnosis; central nervous system disorders; psychological disorders
05/09/2006US7041844 Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer
05/09/2006US7041836 Antibiotic compounds
05/09/2006US7041835 (−)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor
05/09/2006US7041829 Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
05/09/2006US7041828 Phenyl-substituted imidazopyridines
05/09/2006US7041827 Phenyl-substituted imidazopyridines
05/09/2006US7041824 Such as trans-N2-(4-aminocyclohexyl)-N6-(2-aminoethyl)-1H-purine-2,6-diamine trihydrochloride for treatment/prevention of fungal diseases
05/09/2006US7041823 (Famciclovir); reacting the thallium salt of 2-aminopurine and 2-acetoxymethyl-4-bromobut-1-yl-acetate in a polar organic solvent under mild reaction conditions; selective coupling at the 9-position; by-product inhibition; antiviral drug
05/09/2006US7041818 drug delivery system compound; carboxy(C1-4)alkyl-dextran polyalcohol modified with galactose or galactosamine and a residue of an antineoplastic or antiinflammatory agent bound to the carboxy(C1-4)alkyldextran polyalcohol; DX-8951 (Exatecan); liver cancer; improved tumor selectivity
05/09/2006US7041813 Canine herpes virus alpha transinducing factor nucleic acid molecules
05/09/2006US7041806 Netrin receptors
05/09/2006US7041802 Peptidoglycan recognition proteins
05/09/2006US7041706 Orally administering limonene for treating inflammation in the intestines
05/09/2006US7041705 Injectable aqueous dispersions of propofol
05/09/2006US7041704 Particularly a tetrodotoxin-resistant voltage-gated Na+ current (TTX-R INa) and/or activity-dependent sodium channel modulators to treat inflammatory bowel disorders, irritable bowel syndrome, slow-transit constipation, non-ulcer dyspepsia, an evacuation an evacuation disorder and functional dysphasia
05/09/2006US7041703 Particularly septic shock and/or autoimmune pathologies in which the aetiopathogenic role of inflammatory cytokines has been ascertained
05/09/2006US7041702 Pharmaceutically active compounds and methods of use
05/09/2006US7041701 Triterpenoid derivatives
05/09/2006US7041700 Substituted benzopyran derivatives against arrhythmia
05/09/2006US7041699 Ascorbic compound; L-lysine compound; c) L-proline compound; and d) epigallocatechin gallate, epicatechin gallate, epigallocatechin, epicatechin, or catechin; blocking cancer proliferation and metastasis.
05/09/2006US7041698 Tripeptide analogs that inhibit the functioning of the NS3 protease encoded by Hepatitis C virus
05/09/2006US7041697 for the treatment of depression, anxiety, panic disorder, post-traumatic stress disorder, premenstrual disorder, attention deficit disorder, obsessive compulsive disorder, obesity, eating disorders, cocaine and alcohol addiction, sexual dysfunction
05/09/2006US7041696 Induce inflammation, immunology response; autoimmune disease; antiarthritic agents
05/09/2006US7041695 N-sulfonylheterocyclopyrrolyl-alkylamine compounds as 5-hydroxytryptamine-6 ligands
05/09/2006US7041694 Cyclooxygenase-2 inhibition
05/09/2006US7041693 Antiarthritic agents; osteoporosis; antitumor agents; antiulcer agents; antiinflammatory agents
05/09/2006US7041692 Methods of treating factor VIIa-associated conditions with compounds having an amine nucleus
05/09/2006US7041691 E.g., 2-(2,6-Dichloro-4-nitro-phenylsulfanyl)-benzothiazole-5-carboxylic acid methyl ester; modulators of peroxisome proliferator-activated receptors (PPARs) to treat type 11 diabetes and obesity; hypertension, hyperlipidemia, hypercholesterolemia, and hyperlipoproteinemia; antiinflammatory agents
05/09/2006US7041690 Viricides; hepatitis virus infections
05/09/2006US7041689 Heteroaryl substituted spriocyclic sulfamides for inhibition of gamma secretase
05/09/2006US7041688 Alkynly-substituted spirocyclic sulfamides for the treatment of alzheimer's disease
05/09/2006US7041687 Indazole compounds useful as protein kinase inhibitors
05/09/2006US7041686 Substituted imidazoles useful in the treatment of inflammatory diseases
05/09/2006US7041685 Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof
05/09/2006US7041684 4-[2-Hydroxy-3-([4-(5-carbamoyl-2-pyridyloxy)phenyl]-2-methylpropylamino)propoxy]carbazole and salts;treating obesity; antidiabetic agent for non-insulin dependent diabetes (Type II);
05/09/2006US7041683 Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1, 4-benzodiozan
05/09/2006US7041682 Antiemetics, antidepressants, anxiolytic agents, antitussive agents
05/09/2006US7041681 Nitrogen heterocyclic compounds, e.g., 3-(2-oxo-2-phenyl-ethylcarbamoyl)-3,4-dihydro-1H-isoquinoline-2-carboxylic acid tert-butyl ester; treating pain and gastrointestinal disorders.
05/09/2006US7041680 (R) and (S) isomers of substituted 2-(2,6-dioxopiperidin-3-yl) phthalimides and 1-oxoisoindolines and methods of using the same
05/09/2006US7041679 Crystallization, filtration; neurokinins receptor antagonist
05/09/2006US7041678 Alkaloid that inhibits biosynthesis of mycotoxins and method for screening for mycotoxin inhibitors
05/09/2006US7041677 Halogenated flosequinan
05/09/2006US7041676 Compounds, compositions, and methods
05/09/2006US7041675 Invention also relates to the tautomeric forms, and possible enantiomeric and diastereomeric forms of said compounds, to the prodrugs thereof and to their use as PARP inhibitors.